Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01830460

Ligand	Ligand name	Chain	PDB	Tanimoto
421	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	A	1ZSK	0.72
709	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	A	1ZSJ	0.76
BL4	(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	A	3BZ7	0.75
888	3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one	A,B	2FVC	0.7
061	2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE	A,B	1A8T	0.75
D27	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	A,B,C,D	2VD0	0.71
LI7	(3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE	A	1YXX	0.72
968	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	A	1ONZ	0.74
135	N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY-BENZAMIDE	B	1GJA	0.77
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A	1QNF	0.75
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A,B,C,D,I,K	1TEZ	0.75
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A	2J07	0.75
FO1	1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol	A,B,C,D	3C3D	0.75
FO1	1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol	A,B,C,D	3C3E	0.75
BL6	(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	A	3BZ8	0.76
BIT	(-)-1-PHENYL-1,2,3,4-TETRAHYDRO-4-HYDROXYPYRROLO[2,3-B]-7-METHYLQUINOLIN-4-ONE	A	1YV3	0.75
HAB		A,B	1SRE	0.72
794	2-[(CARBOXYCARBONYL)(1-NAPHTHYL)AMINO]BENZOIC ACID	A	1NO6	0.71
FRM	2-{3-[4-(4-FLUOROPHENYL)-3,6-DIHYDRO-1(2H)-PYRIDINYL]PROPYL}-8-METHYL-4(3H)-QUINAZOLINONE	A,B	1UK0	0.71
ANT	ANTHRAMYCIN	A	274D	0.72
TC8	3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one	A	3G3N	0.73
BL7	(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	A	3BZ9	0.75
NU1	8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE	A	4PAX	0.87
MTB		A,B	1SRF	0.71
OPB	4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE	A	1Q7A	0.71
OPB	4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE	A,B	2BXB	0.71
OPB	4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE	A	2BXO	0.71
DMB		A,B	1SRI	0.71
LI6	3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE	A	1YXV	0.71
MHB		A,B	1SRG	0.72
BIJ	7-{[(2Z,5S)-5-CHLORO-2-{[2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL]IMINO}-2,5-DIHYDROPYRIMIDIN-4-YL]AMINO}-2-METHYL-2,3-DIHYDRO-1H-ISOINDOL-1-ONE	A	2JKO	0.7
LJ5	N-(3,5-dibromo-4-hydroxyphenyl)benzamide	A,B	3CN4	0.7
DQB	4-[(4-{[(2-AMINO-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)METHYL]AMINO}BENZOYL)AMINO]BUTANOIC ACID	A	1ZLY	0.7
MRE	2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID	A,B	2V9C	0.71
C00	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	A	3BYX	0.75
C00	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	A	3BZ0	0.75
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV1	0.7
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF2	0.7
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1SL9	0.7
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF0	0.7
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV0	0.7
CZH	C2-HYDROPEROXY-COELENTERAZINE	A,B	1EJ3	0.7
CTZ	C2-HYDROXY-COELENTERAZINE	A	2HPS	0.71
CTZ	C2-HYDROXY-COELENTERAZINE	A	1EL4	0.71